These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 33949772)

  • 1. Nintedanib attenuates peritoneal fibrosis by inhibiting mesothelial-to-mesenchymal transition, inflammation and angiogenesis.
    Liu F; Yu C; Qin H; Zhang S; Fang L; Wang Y; Wang J; Cui B; Hu S; Liu N; Zhuang S
    J Cell Mol Med; 2021 May; 25(13):6103-14. PubMed ID: 33949772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed Administration of Nintedanib Ameliorates Fibrosis Progression in CG-Induced Peritoneal Fibrosis Mouse Model.
    Cui B; Yu C; Zhang S; Hou X; Wang Y; Wang J; Zhuang S; Liu F
    Kidney Dis (Basel); 2022 Jul; 8(4):319-333. PubMed ID: 36157259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase 6 inhibition counteracts the epithelial-mesenchymal transition of peritoneal mesothelial cells and prevents peritoneal fibrosis.
    Xu L; Liu N; Gu H; Wang H; Shi Y; Ma X; Ma S; Ni J; Tao M; Qiu A; Zhuang S
    Oncotarget; 2017 Oct; 8(51):88730-88750. PubMed ID: 29179471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A protective role of nintedanib in peritoneal fibrosis through H19-EZH2-KLF2 axis via impeding mesothelial-to-mesenchymal transition.
    Zhong W; Fu J; Liao J; Ouyang S; Yin W; Liang Y; Liu K
    Int Urol Nephrol; 2024 Jun; 56(6):1987-1999. PubMed ID: 38097887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitro-oleic acid inhibits the high glucose-induced epithelial-mesenchymal transition in peritoneal mesothelial cells and attenuates peritoneal fibrosis.
    Su W; Wang H; Feng Z; Sun J
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F457-F467. PubMed ID: 31760768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Src attenuates peritoneal fibrosis and inhibits the epithelial to mesenchymal transition.
    Wang J; Wang L; Xu L; Shi Y; Liu F; Qi H; Liu N; Zhuang S
    Oncotarget; 2017 Oct; 8(48):83872-83889. PubMed ID: 29137389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis.
    Loureiro J; Sandoval P; del Peso G; Gónzalez-Mateo G; Fernández-Millara V; Santamaria B; Bajo MA; Sánchez-Tomero JA; Guerra-Azcona G; Selgas R; López-Cabrera M; Aguilera AI
    PLoS One; 2013; 8(4):e61165. PubMed ID: 23637793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated protein C inhibits mesothelial-to-mesenchymal transition in experimental peritoneal fibrosis.
    Giri H; Biswas I; Rezaie AR
    J Thromb Haemost; 2023 Jan; 21(1):133-144. PubMed ID: 36695376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of thrombospondin-1 ameliorates high glucose-induced peritoneal fibrosis through downregulation of TGF-β1/Smad3 signaling pathway.
    Jiang N; Zhang Z; Shao X; Jing R; Wang C; Fang W; Mou S; Ni Z
    J Cell Physiol; 2020 Jan; 235(1):364-379. PubMed ID: 31236971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nintedanib, a triple tyrosine kinase inhibitor, attenuates renal fibrosis in chronic kidney disease.
    Liu F; Wang L; Qi H; Wang J; Wang Y; Jiang W; Xu L; Liu N; Zhuang S
    Clin Sci (Lond); 2017 Aug; 131(16):2125-2143. PubMed ID: 28646122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed administration of suramin attenuates peritoneal fibrosis in rats.
    Xiong C; Liu N; Shao X; Sharif S; Zou H; Zhuang S
    BMC Nephrol; 2019 Nov; 20(1):411. PubMed ID: 31727005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis.
    Shi Y; Tao M; Wang Y; Zang X; Ma X; Qiu A; Zhuang S; Liu N
    J Pathol; 2020 Jan; 250(1):79-94. PubMed ID: 31579944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Transglutaminase 2 Reduces Peritoneal Injury in a Chlorhexidine-Induced Peritoneal Fibrosis Model.
    Kunoki S; Tatsukawa H; Sakai Y; Kinashi H; Kariya T; Suzuki Y; Mizuno M; Yamaguchi M; Sasakura H; Ikeno M; Takeuchi K; Ishimoto T; Hitomi K; Ito Y
    Lab Invest; 2023 Apr; 103(4):100050. PubMed ID: 36870292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway.
    Li LF; Kao KC; Liu YY; Lin CW; Chen NH; Lee CS; Wang CW; Yang CT
    J Cell Mol Med; 2017 Nov; 21(11):2937-2949. PubMed ID: 28598023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suramin inhibits the development and progression of peritoneal fibrosis.
    Xiong C; Liu N; Fang L; Zhuang S; Yan H
    J Pharmacol Exp Ther; 2014 Nov; 351(2):373-82. PubMed ID: 25168661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.
    Wollin L; Maillet I; Quesniaux V; Holweg A; Ryffel B
    J Pharmacol Exp Ther; 2014 May; 349(2):209-20. PubMed ID: 24556663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asiaticoside inhibits TGF-β1-induced mesothelial-mesenchymal transition and oxidative stress via the Nrf2/HO-1 signaling pathway in the human peritoneal mesothelial cell line HMrSV5.
    Zhao J; Shi J; Shan Y; Yu M; Zhu X; Zhu Y; Liu L; Sheng M
    Cell Mol Biol Lett; 2020; 25():33. PubMed ID: 32514269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional molecules in mesothelial-to-mesenchymal transition revealed by transcriptome analyses.
    Namvar S; Woolf AS; Zeef LA; Wilm T; Wilm B; Herrick SE
    J Pathol; 2018 Aug; 245(4):491-501. PubMed ID: 29774544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reprogramming of Mesothelial-Mesenchymal Transition in Chronic Peritoneal Diseases by Estrogen Receptor Modulation and TGF-β1 Inhibition.
    Wilson RB; Archid R; Reymond MA
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32532126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling.
    Ueno T; Nakashima A; Doi S; Kawamoto T; Honda K; Yokoyama Y; Doi T; Higashi Y; Yorioka N; Kato Y; Kohno N; Masaki T
    Kidney Int; 2013 Aug; 84(2):297-307. PubMed ID: 23486522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.